Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 17.55
-0.05 (-0.28%)
Last updated: Aug 7, 2026, 11:34 AM CET
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €132.29 million as of August 7, 2026. Its market cap has increased by 219.67% in one year.
Market Cap
132.29M
Enterprise Value
130.09M
Revenue
9.69M
Ranking
n/a
PE Ratio
45.67
Stock Price
€17.55
ChartMarket Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 132.29M, an increase of 760.78%. That is a compound annual growth rate of 63.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 132.29M | 105.64% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.03B |
| Laboratorios Farmaceuticos Rovi | 3.00B |
| Almirall | 2.39B |
| Faes Farma | 1.41B |
| Clínica Baviera | 974.81M |
| Oryzon Genomics | 239.17M |
| Prim, S.A. | 227.06M |
| Laboratorio Reig Jofre | 223.88M |